Regent Peak Wealth Advisors LLC Sells 122 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Regent Peak Wealth Advisors LLC lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,005 shares of the financial services provider’s stock after selling 122 shares during the period. Regent Peak Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $265,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth $30,000. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth $36,000. Modus Advisors LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth $41,000. Finally, Voisard Asset Management Group Inc. acquired a new stake in iShares Biotechnology ETF in the third quarter valued at $59,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.2 %

Shares of IBB stock traded up $1.65 on Tuesday, reaching $135.94. The stock had a trading volume of 953,315 shares, compared to its average volume of 1,000,672. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The firm’s 50-day moving average is $138.56 and its two-hundred day moving average is $142.11.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.